Biogen Idec to cut pipeline and jobs to focus on neurology
This article was originally published in Scrip
Executive Summary
Biogen Idec has finally detailed its cost-cutting and restructuring plans after weeks of speculation. Having concluded that Biogen Idec was "a mile wide and an inch deep", CEO Dr George Scangos said neurology will be the company's main focus.